Results of treating mastodynias and mastopathies with percutaneous progesterone
Mauvais-Jarvis, P.; Kuttenn, F.; Ohlgiesser, C.
La Nouvelle Presse Medicale 3(16): 1027-1028
1974
ISSN/ISBN: 0301-1518 PMID: 4836479 Document Number: 75565
Document emailed within 1 workday
Related Documents
Ciambellotti, E.; Favero, A. 1977: Therapeutic results with a vitamin complex (A,E,B6) in fibrocystic mastopathies Minerva Medica 68(18): 1249-1252Lu, L.A.; Martyniuk, V.V.; Sobolev, A.A. 1998: The goals and possibilities of drug therapy in mastopathies (results of a questionnaire addressed to oncologists in various regions of Russia) Voprosy Onkologii 44(4): 452-454
Cherif-Cheikh, J.L.; de Lignieres, B. 1974: Treatment of seborrhea of the scalp with percutaneous progesterone Semaine des Hopitaux. Therapeutique 50(7-8): 489-491
Roche, J.F.; Gosling, J.P. 1977: Control of estrus and progesterone levels in heifers given intravaginal progesterone coils and injections of progesterone and estrogen Journal of Animal Science 44(6): 1026-1029
Anonymous 2000: Progestins, Progesterone Receptor Modulators, and Progesterone Antagonists. Progesterone, progestins and antiprogestins in the next millennium, Jerusalem, Israel, 31 August-3 September, 1999 Steroids 65(10/11): 543-850
Chanprasopon, P.; Kongchareonsombat, W.; Leenanupunth, C.; Kijvikai, K.; Viseshsindh, W. 2013: The best calyceal tract approach for treating renal stones with percutaneous nephrolithotomy Journal of the Medical Association of Thailand 96(5): 575-579
Janík, V.; Kolihová, E.; Zvĕrina, J.; Kawaciuk, I. 1989: A new method of treating male infertility: percutaneous transfemoral embolization of varicoceles with Vilan 500 Rozhledy V Chirurgii: Mesicnik Ceskoslovenske Chirurgicke Spolecnosti 68(11): 765-770
Mauvais-Jarvis, P. 1985: Why should benign mastopathies be treated medically? Journal de Gynecologie Obstetrique et Biologie de la Reproduction 14(5): 623-626
Engeler, V.; Schreiser, W.E. 1977: Surgical treatment in severe mastopathies Ginecologia y Obstetricia de Mexico 41(245): 215-233
Wang, S.; Shi, G.; Meng, X. 2015: Clinical curative effect of percutaneous vertebroplasty combined with 125I-seed implantation in treating spinal metastatic tumor Pakistan Journal of Pharmaceutical Sciences 28(3 Suppl): 1039-1042
Iaritsyn, S.S.; Sidorenko, L.N. 1979: Pathogenetic therapy of mastopathies in the prevention of breast cancer Voprosy Onkologii 25(3): 52-55
Choe, J.K.; Check, J.H.; Nowroozi, K.; Benveniste, R.; Barnea, E.R. 1992: Serum progesterone and 17-hydroxyprogesterone in the diagnosis of ectopic pregnancies and the value of progesterone replacement in intrauterine pregnancies when serum progesterone levels are low Gynecologic and Obstetric Investigation 34(3): 133-138
Gorins, A.; Netter, A. 1974: Prolactin. Radioimmunoassay in female breast cancers and benign mastopathies La Nouvelle Presse Medicale 3(2): 73-75
Seewald, H.J.; Böhm, W.; Przesang, R. 1977: Results of high dosage progesterone therapy in carcinoma corporis uteri Zentralblatt für Gynakologie 99(7): 392-395
Menges, V.; Wellauer, J.; Engeler, V.; Stadelmann, R. 1973: Correlation of numerically detected microcalcifications on the mammogram and in this manner diagnosed carcinomas and mastopathies Der Radiologe 13(11): 468-476
Guo, Y.-X.; Li, Y.-H.; Chen, Y.; Chen, P.-Y.; Luo, P.-F.; Li, Y.; Shan, H.; Jiang, Z.-B. 2003: Percutaneous transhepatic metal versus plastic biliary stent in treating malignant biliary obstruction: a multiple center investigation Hepatobiliary and Pancreatic Diseases International: Hbpd Int 2(4): 594-597
Pei, H.; Wu, Y.; Yang, Y.; Teng, S.; Zhang, H.; Zhang, L.; Niu, H.; Zhang, W.; Niu, G.; Qian, J.; Qiao, S.; Xu, B.; Gao, R. 2015: Early clinical outcomes of percutaneous balloon aortic valvuloplasty in treating high-risk patients with severe aortic stenosis Zhonghua Xin Xue Guan Bing Za Zhi 43(1): 34-38
Hilborn, S.; Krahn, J. 1987: Effect of time of exposure of serum to gel-barrier tubes on results for progesterone and some other endocrine tests Clinical Chemistry 33(1): 203-204
Richardson, A.P.; Kim, J.B.; Barnard, G.J.; Collins, W.P.; McCapra, F. 1985: Chemiluminescence immunoassay of plasma progesterone, with progesterone-acridinium ester used as the labeled antigen Clinical Chemistry 31(10): 1664-1668
Toivonen, J. 1980: Pituitary and gonadal function during the use of progesterone- or progesterone-estradiol-releasing vaginal rings International Journal of Fertility 25(2): 106-111